My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Oncología (Barcelona)
Print version ISSN 0378-4835
Abstract
GUTIERREZ ABAD, D.; CASADO HERRAEZ, A.; FILIPOVICH VEGAS, E. and HERNANDEZ MURO, G.. Efficacy of the first-line treatment with capecitabin monotherapy of patients with vagina epidermoid carcinoma and lung metastases, in terms of clinical response according to the RECIST criteria. Oncología (Barc.) [online]. 2006, vol.29, n.10, pp.37-39. ISSN 0378-4835.
Literature data about chemotherapy of vaginal metastatic squamous cell carcinoma are limited because of the rare incidence of this kind of tumours. In addition, some patients evaluated in clinical practice, usually are not good candidates for standard treatments or clinical trials. This situation makes new treatments a good choice, unless patients meet the selection criteria to be included in a clinical trial. We present a case of lung metastatic vaginal carcinoma with partial response (RECIST criteria) after three cycles of capecitabine monotherapy.
Keywords : Squamous cell vaginal carcinoma; Lung metastases; Capecitabine.